Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods
- PMID: 28838961
- PMCID: PMC5580266
- DOI: 10.1161/CIRCIMAGING.116.006105
Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods
Abstract
Background: Late gadolinium enhancement (LGE) border zone on cardiac magnetic resonance imaging has been proposed as an independent predictor of ventricular arrhythmias. The purpose was to determine whether size and heterogeneity of LGE predict appropriate implantable cardioverter defibrillator (ICD) therapy in ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM) patients and to evaluate 4 LGE border-zone algorithms.
Methods and results: ICM and NICM patients who underwent LGE cardiac magnetic resonance imaging prior to ICD implantation were retrospectively included. Two semiautomatic algorithms, expectation maximization, weighted intensity, a priori information and a weighted border zone algorithm, were compared with a modified full-width half-maximum and a 2-3SD threshold-based algorithm (2-3SD). Hazard ratios were calculated per 1% increase in LGE. A total of 74 ICM and 34 NICM were followed for 63 months (1-140) and 52 months (0-133), respectively. ICM patients had 27 appropriate ICD events, and NICM patients had 7 ICD events. In ICM patients with primary prophylactic ICD, LGE border zone predicted ICD therapy in univariable and multivariable analysis measured by the expectation maximization, weighted intensity, a priori information, weighted border zone, and modified full-width half-maximum algorithms (hazard ratios 1.23, 1.22, and 1.05, respectively; P<0.05; negative predictive value 92%). For NICM, total LGE by all 4 methods was the strongest predictor (hazard ratios, 1.03-1.04; P<0.05), though the number of events was small.
Conclusions: Appropriate ICD therapy can be predicted in ICM patients with primary prevention ICD by quantifying the LGE border zone. In NICM patients, total LGE but not LGE border zone had predictive value for ICD therapy. However, the algorithms used affects the predictive value of these measures.
Keywords: cardiac magnetic resonance imaging; implanted cardioverter defibrillator; ischemic cardiomyopathy; late gadolinium enhancement; nonischemic cardiomyopathy.
© 2017 American Heart Association, Inc.
Figures



Comment in
-
Unraveling the Scar With Cardiac Magnetic Resonance.Circ Cardiovasc Imaging. 2017 Sep;10(9):e006907. doi: 10.1161/CIRCIMAGING.117.006907. Circ Cardiovasc Imaging. 2017. PMID: 28838964 No abstract available.
-
Letter by Guaricci et al Regarding Article, "Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods".Circ Cardiovasc Imaging. 2018 Jan;11(1):e007213. doi: 10.1161/CIRCIMAGING.117.007213. Circ Cardiovasc Imaging. 2018. PMID: 29305349 No abstract available.
-
Response by Jablonowski et al to Letter Regarding Article, "Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods".Circ Cardiovasc Imaging. 2018 Jan;11(1):e007333. doi: 10.1161/CIRCIMAGING.117.007333. Circ Cardiovasc Imaging. 2018. PMID: 29305351 No abstract available.
Similar articles
-
Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.Circ Cardiovasc Imaging. 2016 Oct;9(10):e004956. doi: 10.1161/CIRCIMAGING.115.004956. Circ Cardiovasc Imaging. 2016. PMID: 27729359
-
Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.J Cardiovasc Magn Reson. 2019 May 16;21(1):28. doi: 10.1186/s12968-019-0536-5. J Cardiovasc Magn Reson. 2019. PMID: 31096987 Free PMC article.
-
Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.Circ Cardiovasc Imaging. 2012 Jul;5(4):448-56. doi: 10.1161/CIRCIMAGING.111.971549. Epub 2012 May 9. Circ Cardiovasc Imaging. 2012. PMID: 22572740
-
Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.JACC Cardiovasc Imaging. 2016 Sep;9(9):1046-1055. doi: 10.1016/j.jcmg.2016.01.033. Epub 2016 Jul 20. JACC Cardiovasc Imaging. 2016. PMID: 27450871 Review.
-
Prognostic Value of Late Gadolinium Enhancement in Predicting Life-Threatening Arrhythmias in Heart Failure Patients With Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis.J Magn Reson Imaging. 2020 May;51(5):1422-1439. doi: 10.1002/jmri.26982. Epub 2019 Nov 11. J Magn Reson Imaging. 2020. PMID: 31710415
Cited by
-
Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data.J Cardiovasc Magn Reson. 2022 Nov 7;24(1):53. doi: 10.1186/s12968-022-00888-8. J Cardiovasc Magn Reson. 2022. PMID: 36336693 Free PMC article.
-
Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: Implications of varying scar ranges.Heart Rhythm. 2022 Oct;19(10):1604-1610. doi: 10.1016/j.hrthm.2022.05.021. Epub 2022 May 26. Heart Rhythm. 2022. PMID: 35644355 Free PMC article.
-
Predicting postinfarct ventricular tachycardia by integrating cardiac MRI and advanced computational reentrant pathway analysis.Heart Rhythm. 2024 Oct;21(10):1962-1969. doi: 10.1016/j.hrthm.2024.04.077. Epub 2024 Apr 24. Heart Rhythm. 2024. PMID: 38670247 Free PMC article.
-
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death.J Cardiovasc Echogr. 2019 Jul-Sep;29(3):89-94. doi: 10.4103/jcecho.jcecho_25_19. J Cardiovasc Echogr. 2019. PMID: 31728298 Free PMC article. Review.
-
The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy.Arrhythm Electrophysiol Rev. 2019 Jul;8(3):191-201. doi: 10.15420/aer.2019.5.1. Arrhythm Electrophysiol Rev. 2019. PMID: 31463057 Free PMC article. Review.
References
-
- Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334–2351. - PubMed
-
- Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA. 2004;292:2874–79. - PubMed
-
- Kadish A, Dyer A, Daubert JP, Quigg R, Estes NM, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350:2151–58. - PubMed
-
- Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83. - PubMed
-
- Bardy G, Lee K, Mark D, Poole J. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–237. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical